Lecanemab is expected to work in Alzheimer's disease by reducing the build-up of sticky plaques known as beta amyloid in the brain. This is one of the likely causes of the development of this disease.
Research conducted on a group of almost 1.8 thousand patients with early-stage Alzheimer's disease showed that administering the injections at two-week intervals improved memory and...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
